Compare ALEMBIC PHARMA with Biocon - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs BIOCON - Comparison Results

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA BIOCON ALEMBIC PHARMA/
BIOCON
 
P/E (TTM) x 16.3 34.7 46.9% View Chart
P/BV x 6.5 4.4 147.2% View Chart
Dividend Yield % 0.6 0.2 263.2%  

Financials

 ALEMBIC PHARMA   BIOCON
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
BIOCON
Mar-19
ALEMBIC PHARMA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs664707 93.9%   
Low Rs412554 74.5%   
Sales per share (Unadj.) Rs208.791.9 227.1%  
Earnings per share (Unadj.) Rs31.016.7 185.5%  
Cash flow per share (Unadj.) Rs37.124.2 153.5%  
Dividends per share (Unadj.) Rs5.501.00 550.0%  
Dividend yield (eoy) %1.00.2 644.4%  
Book value per share (Unadj.) Rs144.2101.6 141.9%  
Shares outstanding (eoy) m188.52600.00 31.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.66.9 37.6%   
Avg P/E ratio x17.437.7 46.0%  
P/CF ratio (eoy) x14.526.1 55.6%  
Price / Book Value ratio x3.76.2 60.2%  
Dividend payout %17.76.0 296.5%   
Avg Mkt Cap Rs m101,461378,330 26.8%   
No. of employees `000NA6.1 0.0%   
Total wages/salary Rs m7,46711,653 64.1%   
Avg. sales/employee Rs ThNM8,994.3-  
Avg. wages/employee Rs ThNM1,900.7-  
Avg. net profit/employee Rs ThNM1,635.3-  
INCOME DATA
Net Sales Rs m39,34755,144 71.4%  
Other income Rs m941,444 6.5%   
Total revenues Rs m39,44156,588 69.7%   
Gross profit Rs m8,73615,883 55.0%  
Depreciation Rs m1,1524,478 25.7%   
Interest Rs m184709 26.0%   
Profit before tax Rs m7,49312,140 61.7%   
Minority Interest Rs m119 120.0%   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5682,123 73.8%   
Profit after tax Rs m5,84410,026 58.3%  
Gross profit margin %22.228.8 77.1%  
Effective tax rate %20.917.5 119.6%   
Net profit margin %14.918.2 81.7%  
BALANCE SHEET DATA
Current assets Rs m19,57748,228 40.6%   
Current liabilities Rs m14,89630,376 49.0%   
Net working cap to sales %11.932.4 36.7%  
Current ratio x1.31.6 82.8%  
Inventory Days Days9068 131.4%  
Debtors Days Days4586 53.0%  
Net fixed assets Rs m27,09764,130 42.3%   
Share capital Rs m3773,000 12.6%   
"Free" reserves Rs m26,81157,980 46.2%   
Net worth Rs m27,18860,980 44.6%   
Long term debt Rs m4,99315,766 31.7%   
Total assets Rs m47,778121,924 39.2%  
Interest coverage x41.718.1 230.1%   
Debt to equity ratio x0.20.3 71.0%  
Sales to assets ratio x0.80.5 182.1%   
Return on assets %12.68.8 143.3%  
Return on equity %21.516.4 130.7%  
Return on capital %23.616.8 140.9%  
Exports to sales %028.1 0.0%   
Imports to sales %018.9 0.0%   
Exports (fob) Rs mNA15,506 0.0%   
Imports (cif) Rs mNA10,399 0.0%   
Fx inflow Rs m19,45315,506 125.5%   
Fx outflow Rs m6,06510,399 58.3%   
Net fx Rs m13,3885,107 262.1%   
CASH FLOW
From Operations Rs m8,12011,546 70.3%  
From Investments Rs m-7,556-7,138 105.9%  
From Financial Activity Rs m590-2,417 -24.4%  
Net Cashflow Rs m1,1532,103 54.8%  

Share Holding

Indian Promoters % 74.1 40.4 183.4%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 2.9 8.4 34.5%  
FIIs % 9.1 10.7 85.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 19.9 69.8%  
Shareholders   49,328 109,995 44.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DR. REDDYS LAB  IPCA LABS  JUBILANT LIFE SCIENCES  NEULAND LABS  PIRAMAL ENTERPRISES  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 300 Points Higher; Dow Futures Up by 39 Points(12:30 pm)

Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 337 points, up 0.7% at 50,129 levels.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 21, 2021 01:44 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS